A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors
- 2 July 2001
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 96 (2) , 183-188
- https://doi.org/10.1016/s0166-0934(01)00330-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Broad-Spectrum Antiviral Activity and Mechanism of Antiviral Action of the Fluoroquinolone Derivative K-12Antiviral Chemistry and Chemotherapy, 1998
- S-Adenosylhomocysteine Hydrolase Inhibitors Interfere with the Replication of Human Immunodeficiency Virus Type 1 through Inhibition of the LTR TransactivationMolecular Pharmacology, 1997
- Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitroGenes & Development, 1997
- P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroGenes & Development, 1997
- Detection of HIV-1 Infection with a Green Fluorescent Protein Reporter SystemJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335Antimicrobial Agents and Chemotherapy, 1992
- Inhibition of HIV Replication in Acute and Chronic Infections in Vitro by a Tat AntagonistScience, 1991
- The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.Proceedings of the National Academy of Sciences, 1991
- Regulation of expression driven by human immunodeficiency virus type 1 and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cellsJournal of Virology, 1988
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeatCell, 1985